Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kapp, OH; Siemion, J; Kuo, J; Johnson, BA; Shankaran, V; Reba, RC; Mukherjee, J
   Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: a molecular modeling study
   JOURNAL OF MOLECULAR MODELING
   
   O.H. Kapp et al., "Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: a molecular modeling study", J MOL MODEL, 7(1-3), 2001, pp. 6-18
2. Newbold, P; Jackson, DM; Young, A; Dougall, IG; Ince, F; Rocchiccioli, KMS; Holt, PR
   Dual D-2 dopamine receptor and beta(2)-adrenoceptor agonists for the modulation of sensory nerves in COPD
   NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
   
   P. Newbold et al., "Dual D-2 dopamine receptor and beta(2)-adrenoceptor agonists for the modulation of sensory nerves in COPD", PROG R RES, 31, 2001, pp. 68-71
3. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
   Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects
   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
   
   L. Gimenez-Llort et al., "Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects", ENV TOX PH, 9(3), 2001, pp. 61-70
4. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
   Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly
   MOLECULAR PSYCHIATRY
   
   S. Govoni et al., "Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly", MOL PSYCHI, 6(2), 2001, pp. 134-142
5. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
   How do the atypical antipsychotics work?
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   J. Ananth et al., "How do the atypical antipsychotics work?", J PSYCH NEU, 26(5), 2001, pp. 385-394
6. Tauscher, J; Kapur, S
   Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies
   CNS DRUGS
   
   J. Tauscher e S. Kapur, "Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies", CNS DRUGS, 15(9), 2001, pp. 671-678
7. Shen, DHY; Kloos, RT; Mazzaferri, EL; Jhiang, SM
   Sodium iodide symporter in health and disease
   THYROID
   
   D.H.Y. Shen et al., "Sodium iodide symporter in health and disease", THYROID, 11(5), 2001, pp. 415-425
8. Ishiwata, K; Kobayashi, T; Kawamura, K; Matsuno, K; Senda, M
   [C-11]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [C-11]SA4503 binding was not by raclopride
   NUCLEAR MEDICINE AND BIOLOGY
   
   K. Ishiwata et al., "[C-11]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [C-11]SA4503 binding was not by raclopride", NUCL MED BI, 28(7), 2001, pp. 787-792
9. Robinet, EA; Wurch, T; Pauwels, PJ
   Different regulation of RGS2 mRNA by haloperidol and clozapine
   NEUROREPORT
   
   E.A. Robinet et al., "Different regulation of RGS2 mRNA by haloperidol and clozapine", NEUROREPORT, 12(8), 2001, pp. 1731-1735
10. Mercier, D; Falardeau, P; Levesque, D
    Autoreceptor preference of dopamine D-2 receptor agonist correlates with preferential coupling to cyclic AMP
    NEUROREPORT
    
    D. Mercier et al., "Autoreceptor preference of dopamine D-2 receptor agonist correlates with preferential coupling to cyclic AMP", NEUROREPORT, 12(7), 2001, pp. 1473-1479
11. Lanser, MG; Ellenbroek, BA; Zitman, FG; Heeren, DJ; Cools, AR
    The role of medial prefrontal cortical dopamine in spontaneous flexibilityin the rat
    BEHAVIOURAL PHARMACOLOGY
    
    M.G. Lanser et al., "The role of medial prefrontal cortical dopamine in spontaneous flexibilityin the rat", BEHAV PHARM, 12(3), 2001, pp. 163-171
12. Markianos, M; Hatzimanolis, J; Lykouras, L
    Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    
    M. Markianos et al., "Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol", EUR ARCH PS, 251(3), 2001, pp. 141-146
13. Wadenberg, MLG; Soliman, A; VanderSpek, SC; Kapur, S
    Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects
    NEUROPSYCHOPHARMACOLOGY
    
    M.L.G. Wadenberg et al., "Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects", NEUROPSYCH, 25(5), 2001, pp. 633-641
14. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
    Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"
    NEUROPSYCHOPHARMACOLOGY
    
    J.J. Clifford et al., "Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"", NEUROPSYCH, 25(4), 2001, pp. 527-536
15. Okauchi, T; Suhara, T; Maeda, J; Kawabe, K; Obayashi, S; Suzuki, K
    Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET
    SYNAPSE
    
    T. Okauchi et al., "Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET", SYNAPSE, 41(2), 2001, pp. 87-95
16. Joel, D
    Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease
    MOVEMENT DISORDERS
    
    D. Joel, "Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease", MOVEMENT D, 16(3), 2001, pp. 407-423
17. Ohngemach, S; Feldkaemper, M; Schaeffel, F
    Pineal control of the dopamine D-2-receptor gene and dopamine release in the retina of the chicken and their possible relation to growth rhythms of the eye
    JOURNAL OF PINEAL RESEARCH
    
    S. Ohngemach et al., "Pineal control of the dopamine D-2-receptor gene and dopamine release in the retina of the chicken and their possible relation to growth rhythms of the eye", J PINEAL R, 31(2), 2001, pp. 145-154
18. Higgins, DS
    Chorea and its disorders
    NEUROLOGIC CLINICS
    
    D.S. Higgins, "Chorea and its disorders", NEUROL CLIN, 19(3), 2001, pp. 707
19. Csende, F
    A simple procedure for synthesis of roxindole, a dopamine D-2-receptor agonist
    ARCHIV DER PHARMAZIE
    
    F. Csende, "A simple procedure for synthesis of roxindole, a dopamine D-2-receptor agonist", ARCH PHARM, 334(7), 2001, pp. 253-254
20. Freeman, A; Ciliax, B; Bakay, R; Daley, J; Miller, RD; Keating, G; Levey, A; Rye, D
    Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models
    ANNALS OF NEUROLOGY
    
    A. Freeman et al., "Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models", ANN NEUROL, 50(3), 2001, pp. 321-329
21. Tranquart, F; Saliba, E; Barantin, L; Lanneau, M; Simmer, L; Guilloteau, D; Baulieu, JL
    D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT
    CLINICAL NUCLEAR MEDICINE
    
    F. Tranquart et al., "D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT", CLIN NUCL M, 26(1), 2001, pp. 36-40
22. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
    Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients
    PSYCHONEUROENDOCRINOLOGY
    
    E. Esel et al., "Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients", PSYCHONEURO, 26(6), 2001, pp. 641-647
23. Levant, B; McCarson, KE
    D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function
    NEUROSCIENCE LETTERS
    
    B. Levant e K.E. McCarson, "D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function", NEUROSCI L, 303(1), 2001, pp. 9-12
24. Yasuno, F; Suhara, T; Sudo, Y; Yamamoto, M; Inoue, M; Okubo, Y; Suzuki, K
    Relation among dopamine D-2 receptor binding, obesity and personality in normal human subjects
    NEUROSCIENCE LETTERS
    
    F. Yasuno et al., "Relation among dopamine D-2 receptor binding, obesity and personality in normal human subjects", NEUROSCI L, 300(1), 2001, pp. 59-61
25. Bullock, CM; Li, C; Li, M; Bermak, JC; Zhou, QY
    Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    C.M. Bullock et al., "Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists", PROG NEUR-P, 25(7), 2001, pp. 1387-1402
26. Mawlawi, O; Martinez, D; Slifstein, M; Broft, A; Chatterjee, R; Hwang, DR; Huang, YY; Simpson, N; Ngo, K; Van Heertum, R; Laruelle, M
    Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D-2 receptor parameter measurements inventral striatum
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    O. Mawlawi et al., "Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D-2 receptor parameter measurements inventral striatum", J CEREBR B, 21(9), 2001, pp. 1034-1057
27. Prasad, BM; Amara, SG
    The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage
    JOURNAL OF NEUROSCIENCE
    
    B.M. Prasad e S.G. Amara, "The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage", J NEUROSC, 21(19), 2001, pp. 7561-7567
28. King, MA; Bradshaw, S; Chang, AH; Pintar, JE; Pasternak, GW
    Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system
    JOURNAL OF NEUROSCIENCE
    
    M.A. King et al., "Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system", J NEUROSC, 21(19), 2001, pp. 7788-7792
29. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
    Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
    JOURNAL OF NEUROSCIENCE
    
    E. Bezard et al., "Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease", J NEUROSC, 21(17), 2001, pp. 6853-6861
30. Manzanedo, C; Serrano, A; Aguilar, MA; Rodriguez-Arias, M; Minarro, J
    Effects of CGS 10746B on hyperactivity and place preference induced by morphine
    BEHAVIOURAL BRAIN RESEARCH
    
    C. Manzanedo et al., "Effects of CGS 10746B on hyperactivity and place preference induced by morphine", BEH BRA RES, 126(1-2), 2001, pp. 23-32
31. Feigin, A; Leenders, KL; Moeller, JR; Missimer, J; Kuenig, G; Spetsieris, P; Antonini, A; Eidelberg, D
    Metabolic network abnormalities in early Huntington's disease: An [F-18]FDG PET study
    JOURNAL OF NUCLEAR MEDICINE
    
    A. Feigin et al., "Metabolic network abnormalities in early Huntington's disease: An [F-18]FDG PET study", J NUCL MED, 42(11), 2001, pp. 1591-1595
32. Urbain, JLC
    Invited commentary - Reporter genes and imagene
    JOURNAL OF NUCLEAR MEDICINE
    
    J.L.C. Urbain, "Invited commentary - Reporter genes and imagene", J NUCL MED, 42(1), 2001, pp. 106-109
33. Davidson, M
    Long-term safety of risperidone
    JOURNAL OF CLINICAL PSYCHIATRY
    
    M. Davidson, "Long-term safety of risperidone", J CLIN PSY, 62, 2001, pp. 26-28
34. Anghelescu, I; Germeyer, S; Muller, MJ; Klawe, C; Singer, P; Dahmen, N; Wetzel, H; Himmerich, H; Szegedi, A
    No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    
    I. Anghelescu et al., "No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria", ALC CLIN EX, 25(6), 2001, pp. 805-809
35. Baker, RW; Osman, J; Bodnar, RJ
    Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    R.W. Baker et al., "Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet", PHARM BIO B, 69(1-2), 2001, pp. 201-208
36. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
    Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    M.L.G. Wadenberg et al., "Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats", PHARM BIO B, 68(3), 2001, pp. 363-370
37. Harvey, BH; Scheepers, A; Brand, L; Stein, DJ
    Chronic inositol increases striatal D-2 receptors but does not modify dexamphetamine-induced motor behavior - Relevance to obsessive-compulsive disorder
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    B.H. Harvey et al., "Chronic inositol increases striatal D-2 receptors but does not modify dexamphetamine-induced motor behavior - Relevance to obsessive-compulsive disorder", PHARM BIO B, 68(2), 2001, pp. 245-253
38. Kapur, S; Remington, G
    Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
    ANNUAL REVIEW OF MEDICINE
    
    S. Kapur e G. Remington, "Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia", ANN R MED, 52, 2001, pp. 503-517
39. Werkman, TR; Kruse, CG; Nievelstein, H; Long, SK; Wadman, WJ
    In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs
    NEUROPHARMACOLOGY
    
    T.R. Werkman et al., "In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs", NEUROPHARM, 40(7), 2001, pp. 927-936
40. Inoue, M; Suhara, T; Sudo, Y; Okubo, Y; Yasuno, F; Kishimoto, T; Yoshikawa, K; Tanada, S
    Age-related reduction of extrastriatal dopamine D-2 receptor measured by PET
    LIFE SCIENCES
    
    M. Inoue et al., "Age-related reduction of extrastriatal dopamine D-2 receptor measured by PET", LIFE SCI, 69(9), 2001, pp. 1079-1084
41. Kim, HJ; Koh, PO; Kang, SS; Paik, WY; Choi, WS
    The localization of dopamine D2 receptor mRNA in the human placenta and the anti-angiogenic effect of apomorphine in the chorioallantoic membrane
    LIFE SCIENCES
    
    H.J. Kim et al., "The localization of dopamine D2 receptor mRNA in the human placenta and the anti-angiogenic effect of apomorphine in the chorioallantoic membrane", LIFE SCI, 68(9), 2001, pp. 1031-1040
42. Thanos, PK; Volkow, ND; Freimuth, P; Umegaki, H; Ikari, H; Roth, G; Ingram, DK; Hitzemann, R
    Overexpression of dopamine D2 receptors reduces alcohol self-administration
    JOURNAL OF NEUROCHEMISTRY
    
    P.K. Thanos et al., "Overexpression of dopamine D2 receptors reduces alcohol self-administration", J NEUROCHEM, 78(5), 2001, pp. 1094-1103
43. Rahman, S; McBride, WJ
    D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA)
    JOURNAL OF NEUROCHEMISTRY
    
    S. Rahman e W.J. McBride, "D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA)", J NEUROCHEM, 77(5), 2001, pp. 1248-1255
44. Wilson, J; Lin, H; Fu, DY; Javitch, JA; Strange, PG
    Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation
    JOURNAL OF NEUROCHEMISTRY
    
    J. Wilson et al., "Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation", J NEUROCHEM, 77(2), 2001, pp. 493-504
45. Ichikawa, J; Ishii, H; Bonaccorso, S; Fowler, WL; O'Laughlin, IA; Meltzer, HY
    5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-inducedcortical dopamine release
    JOURNAL OF NEUROCHEMISTRY
    
    J. Ichikawa et al., "5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-inducedcortical dopamine release", J NEUROCHEM, 76(5), 2001, pp. 1521-1531
46. Wurch, T; Matsumoto, A; Pauwels, PJ
    Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins
    FEBS LETTERS
    
    T. Wurch et al., "Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins", FEBS LETTER, 507(1), 2001, pp. 109-113
47. Johnston, CA; Cumbay, MG; Vortherms, TA; Watts, VJ
    Adrenergic agonists induce heterologous sensitization of adenylate cyclasein NS20Y-D-2L cells
    FEBS LETTERS
    
    C.A. Johnston et al., "Adrenergic agonists induce heterologous sensitization of adenylate cyclasein NS20Y-D-2L cells", FEBS LETTER, 497(2-3), 2001, pp. 85-89
48. Sugimoto, Y; Ohkura, M; Inoue, K; Yamada, J
    Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    Y. Sugimoto et al., "Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice", EUR J PHARM, 430(2-3), 2001, pp. 265-268
49. Hasegawa, M; Adachi, K; Nakamura, S; Sato, M; Waddington, JL; Koshikawa, N
    Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D-1-like receptors in jaw movements
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    M. Hasegawa et al., "Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D-1-like receptors in jaw movements", EUR J PHARM, 423(2-3), 2001, pp. 171-178
50. Tomiyama, K; McNamara, FN; Clifford, JJ; Kinsella, A; Koshikawa, N; Waddington, JL
    Topographical assessment and pharmacological characterization of orofacialmovements in mice: dopamine D-1-like vs. D-2-like receptor regulation
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    K. Tomiyama et al., "Topographical assessment and pharmacological characterization of orofacialmovements in mice: dopamine D-1-like vs. D-2-like receptor regulation", EUR J PHARM, 418(1-2), 2001, pp. 47-54
51. Gao, X; Zhang, YQ; Wu, GC
    Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    X. Gao et al., "Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats", EUR J PHARM, 418(1-2), 2001, pp. 73-77
52. Tahar, AH; Ekesbo, A; Gregoire, L; Bangassoro, E; Svensson, KA; Tedroff, J; Bedard, PJ
    Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    A.H. Tahar et al., "Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys", EUR J PHARM, 412(3), 2001, pp. 247-254
53. Curran, MP; Perry, CM
    Amisulpride - A review of its use in the management of schizophrenia
    DRUGS
    
    M.P. Curran e C.M. Perry, "Amisulpride - A review of its use in the management of schizophrenia", DRUGS, 61(14), 2001, pp. 2123-2150
54. Bhana, N; Foster, RH; Olney, R; Plosker, GL
    Olanzapine - An updated review of its use in the management of schizophrenia
    DRUGS
    
    N. Bhana et al., "Olanzapine - An updated review of its use in the management of schizophrenia", DRUGS, 61(1), 2001, pp. 111-161
55. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
    Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B. Weber et al., "Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists", BR J PHARM, 133(8), 2001, pp. 1243-1248
56. Yoshikawa, T; Yoshida, N; Oka, M
    The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T. Yoshikawa et al., "The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist", BR J PHARM, 133(2), 2001, pp. 253-260
57. Greba, Q; Gifkins, A; Kokkinidis, L
    Inhibition of amygdaloid dopamine D-2 receptors impairs emotional learningmeasured with fear-potentiated startle
    BRAIN RESEARCH
    
    Q. Greba et al., "Inhibition of amygdaloid dopamine D-2 receptors impairs emotional learningmeasured with fear-potentiated startle", BRAIN RES, 899(1-2), 2001, pp. 218-226
58. Konradi, C; Heckers, S
    Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia
    BIOLOGICAL PSYCHIATRY
    
    C. Konradi e S. Heckers, "Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia", BIOL PSYCHI, 50(10), 2001, pp. 729-742
59. Bairam, A; Kinkead, R; Marchal, F
    Age-dependent effect of domperidone on dopamine release by the hypoxic carotid body in the rabbit
    BIOLOGY OF THE NEONATE
    
    A. Bairam et al., "Age-dependent effect of domperidone on dopamine release by the hypoxic carotid body in the rabbit", BIOL NEONAT, 80(3), 2001, pp. 235-238
60. Foley, JF; Kelley, LP; Kinsella, BT
    Prostaglandin D-2 receptor-mediated desensitization of the alpha isoform of the human thromboxane A(2) receptor
    BIOCHEMICAL PHARMACOLOGY
    
    J.F. Foley et al., "Prostaglandin D-2 receptor-mediated desensitization of the alpha isoform of the human thromboxane A(2) receptor", BIOCH PHARM, 62(2), 2001, pp. 229-239
61. Hubl, D; Kleinlogel, H; Frohlich, L; Weinandi, T; Maurer, K; Holstein, W; Czekalla, J; Dierks, T
    Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine
    PSYCHOPHARMACOLOGY
    
    D. Hubl et al., "Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine", PSYCHOPHAR, 158(3), 2001, pp. 281-288
62. Yasuno, F; Suhara, T; Okubo, Y; Sudo, Y; Inoue, M; Ichimiya, T; Tanada, S
    Dose relationship of limbic-cortical D-2-dopamine receptor occupancy with risperidone
    PSYCHOPHARMACOLOGY
    
    F. Yasuno et al., "Dose relationship of limbic-cortical D-2-dopamine receptor occupancy with risperidone", PSYCHOPHAR, 154(1), 2001, pp. 112-114
63. Lena, I; Dhotel, H; Garbay, C; Dauge, V
    Involvement of D-2 dopamine receptors in the opposing effects of two CCK-Bagonists in a spatial recognition memory task: role of the anterior nucleus accumbens
    PSYCHOPHARMACOLOGY
    
    I. Lena et al., "Involvement of D-2 dopamine receptors in the opposing effects of two CCK-Bagonists in a spatial recognition memory task: role of the anterior nucleus accumbens", PSYCHOPHAR, 153(2), 2001, pp. 170-179
64. Goldstein, JM
    The new generation of antipsychotic drugs: how atypical are they?
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    
    J.M. Goldstein, "The new generation of antipsychotic drugs: how atypical are they?", IN J NEUROP, 3(4), 2000, pp. 339-349
65. Loh, EW; Higuchi, S; Matsushita, S; Murray, R; Chen, CK; Ball, D
    Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population
    MOLECULAR PSYCHIATRY
    
    E.W. Loh et al., "Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population", MOL PSYCHI, 5(3), 2000, pp. 301-307
66. Jalaie, M; Lipkowitz, KB
    Published force field parameters for molecular mechanics, molecular dynamics, and Monte Carlo simulations
    REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 14
    
    M. Jalaie e K.B. Lipkowitz, "Published force field parameters for molecular mechanics, molecular dynamics, and Monte Carlo simulations", REV COMP CH, 14, 2000, pp. 441-486
67. Hwang, DR; Kegeles, LS; Laruelle, M
    (-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors
    NUCLEAR MEDICINE AND BIOLOGY
    
    D.R. Hwang et al., "(-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors", NUCL MED BI, 27(6), 2000, pp. 533-539
68. Samochowiec, J; Ladehoff, M; Pelz, J; Smolka, M; Schmidt, LG; Rommelspacher, H; Finckh, U
    Predominant influence of the 3 '-region of dopamine D-2 receptor gene (DRD2) on the clinical phenotype in German alcoholics
    PHARMACOGENETICS
    
    J. Samochowiec et al., "Predominant influence of the 3 '-region of dopamine D-2 receptor gene (DRD2) on the clinical phenotype in German alcoholics", PHARMACOGEN, 10(5), 2000, pp. 471-475
69. Ogawa, O; Umegaki, H; Ishiwata, K; Asai, Y; Ikari, H; Oda, K; Toyama, H; Ingram, DK; Roth, GS; Iguchi, A; Senda, M
    In vivo imaging of adenovirus-mediated over-expression of dopamine D-2 receptors in rat striatum by positron emission tomography
    NEUROREPORT
    
    O. Ogawa et al., "In vivo imaging of adenovirus-mediated over-expression of dopamine D-2 receptors in rat striatum by positron emission tomography", NEUROREPORT, 11(4), 2000, pp. 743-748
70. Terasmaa, A; Andbjer, B; Fuxe, K; Rinken, A
    Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes
    NEUROREPORT
    
    A. Terasmaa et al., "Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes", NEUROREPORT, 11(12), 2000, pp. 2691-2694
71. Perachon, S; Betancur, C; Pilon, C; Rostene, W; Schwartz, JC; Sokoloff, P
    Role of dopamine D-3 receptors in thermoregulation: a reappraisal
    NEUROREPORT
    
    S. Perachon et al., "Role of dopamine D-3 receptors in thermoregulation: a reappraisal", NEUROREPORT, 11(1), 2000, pp. 221-225
72. Dringenberg, HC; Wightman, M; Beninger, RJ
    The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats
    BEHAVIOURAL PHARMACOLOGY
    
    H.C. Dringenberg et al., "The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats", BEHAV PHARM, 11(6), 2000, pp. 447-454
73. Prinssen, EPM; Koek, W; Colpaert, FC; Kleven, MS
    Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced
    BEHAVIOURAL PHARMACOLOGY
    
    E.P.M. Prinssen et al., "Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced", BEHAV PHARM, 11(3-4), 2000, pp. 299-305
74. Oades, RD; Rao, ML; Bender, S; Sartory, G; Muller, BW
    Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D-2-receptor occupancy
    BEHAVIOURAL PHARMACOLOGY
    
    R.D. Oades et al., "Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D-2-receptor occupancy", BEHAV PHARM, 11(3-4), 2000, pp. 317-330
75. Siemiatkowski, M; Sienkiewicz-Jarosz, H; Czlonkowska, AI; Szyndler, J; Bidzinski, A; Plaznik, A
    The effects of dopamine D-2 receptor ligands on novelty-induced behavior in the rat open field test
    NEUROSCIENCE RESEARCH COMMUNICATIONS
    
    M. Siemiatkowski et al., "The effects of dopamine D-2 receptor ligands on novelty-induced behavior in the rat open field test", NEUROSC R C, 27(3), 2000, pp. 155-163
76. Kroncke, KD; Carlberg, C
    Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide
    FASEB JOURNAL
    
    K.D. Kroncke e C. Carlberg, "Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide", FASEB J, 14(1), 2000, pp. 166-173
77. Tsukada, H; Harada, N; Nishiyama, S; Ohba, H; Sato, K; Fukumoto, D; Kakiuchi, T
    Ketamine decreased striatal [C-11]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in themonkey brain: Multiparametric PET studies combined with microdialysis analysis
    SYNAPSE
    
    H. Tsukada et al., "Ketamine decreased striatal [C-11]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in themonkey brain: Multiparametric PET studies combined with microdialysis analysis", SYNAPSE, 37(2), 2000, pp. 95-103
78. Pinborg, LH; Videbaek, C; Knudsen, GM; Swahn, CG; Halldin, C; Friberg, L; Paulson, OB; Lassen, NA
    Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion
    SYNAPSE
    
    L.H. Pinborg et al., "Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion", SYNAPSE, 36(4), 2000, pp. 322-329
79. Weissenborn, K; Berding, G; Kostler, H
    Altered striatal dopamine D-2 receptor density and dopamine transport in apatient with hepatic encephalopathy
    METABOLIC BRAIN DISEASE
    
    K. Weissenborn et al., "Altered striatal dopamine D-2 receptor density and dopamine transport in apatient with hepatic encephalopathy", METAB BRAIN, 15(3), 2000, pp. 173-178
80. Grevle, L; Guzey, C; Hadidi, H; Brennersted, R; Idle, JR; Aasly, J
    Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease
    MOVEMENT DISORDERS
    
    L. Grevle et al., "Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease", MOVEMENT D, 15(6), 2000, pp. 1070-1074
81. Xu, XH; Stewart, JT
    Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    X.H. Xu e J.T. Stewart, "Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives", J PHARM B, 23(4), 2000, pp. 735-743
82. Willson, VJC; Preston, JR; Lockley, WJS; Mather, A; Singh, J; Wilkinson, D
    A RIA combined with SPE for the determination of a dual D-2-receptor and beta(2)-adrenoceptor agonist, AR-C68397XX, in human plasma
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    V.J.C. Willson et al., "A RIA combined with SPE for the determination of a dual D-2-receptor and beta(2)-adrenoceptor agonist, AR-C68397XX, in human plasma", J PHARM B, 22(1), 2000, pp. 155-163
83. Chong, SA; Remington, G
    Clozapine augmentation: Safety and efficacy
    SCHIZOPHRENIA BULLETIN
    
    S.A. Chong e G. Remington, "Clozapine augmentation: Safety and efficacy", SCHIZO BULL, 26(2), 2000, pp. 421-440
84. Tahar, AH; Gregoire, L; Bangassoro, E; Bedard, PJ
    Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys
    CLINICAL NEUROPHARMACOLOGY
    
    A.H. Tahar et al., "Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys", CLIN NEUROP, 23(4), 2000, pp. 195-202
85. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
    Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    H. Vilkman et al., "Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis", EUR J NUCL, 27(11), 2000, pp. 1666-1673
86. Levens, N; Green, TA; Akins, CK; Bardo, MT
    Dopamine D-2-like receptor binding in the brain of male Japanese quail (Coturnix japonica)
    NEUROSCIENCE LETTERS
    
    N. Levens et al., "Dopamine D-2-like receptor binding in the brain of male Japanese quail (Coturnix japonica)", NEUROSCI L, 296(2-3), 2000, pp. 77-80
87. Wong, AHC; Knapp, MGL; Van Tol, HHM
    Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: rotational behaviour
    NEUROSCIENCE LETTERS
    
    A.H.C. Wong et al., "Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: rotational behaviour", NEUROSCI L, 291(3), 2000, pp. 135-138
88. Araki, T; Tanji, H; Fujihara, K; Kato, H; Imai, Y; Mizugaki, M; Itoyama, Y
    Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats
    JOURNAL OF NEURAL TRANSMISSION
    
    T. Araki et al., "Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats", J NEURAL TR, 107(8-9), 2000, pp. 873-884
89. Kusumi, I; Takahashi, Y; Suzuki, K; Kameda, K; Koyama, T
    Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D-2 and serotonin 5-HT2A receptors in the rat brain
    JOURNAL OF NEURAL TRANSMISSION
    
    I. Kusumi et al., "Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D-2 and serotonin 5-HT2A receptors in the rat brain", J NEURAL TR, 107(3), 2000, pp. 295-302
90. Zahniser, NR; Simosky, JK; Mayfield, RD; Negri, CA; Hanania, T; Larson, GA; Kelly, MA; Grandy, DK; Rubinstein, M; Low, MJ; Fredholm, BB
    Functional uncoupling of adenosine A(2A) receptors and reduced response tocaffeine in mice lacking dopamine D-2 receptors
    JOURNAL OF NEUROSCIENCE
    
    N.R. Zahniser et al., "Functional uncoupling of adenosine A(2A) receptors and reduced response tocaffeine in mice lacking dopamine D-2 receptors", J NEUROSC, 20(16), 2000, pp. 5949-5957
91. Meisenzahl, EM; Dresel, S; Frodl, T; Schmitt, GJE; Preuss, UW; Rossmuller, B; Tatsch, K; Mager, T; Hahn, K; Moller, HJ
    D-2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study
    JOURNAL OF PSYCHOPHARMACOLOGY
    
    E.M. Meisenzahl et al., "D-2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study", J PSYCHOPH, 14(4), 2000, pp. 364-370
92. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
    Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
    NEUROBIOLOGY OF AGING
    
    V. Kaasinen et al., "Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain", NEUROBIOL A, 21(5), 2000, pp. 683-688
93. Matochik, JA; Chefer, SI; Lane, MA; Woolf, RI; Morris, ED; Ingram, DK; Roth, GS; London, ED
    Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging
    NEUROBIOLOGY OF AGING
    
    J.A. Matochik et al., "Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging", NEUROBIOL A, 21(4), 2000, pp. 591-598
94. Horacek, J
    Novel antipsychotics and extrapyramidal side effects. Theory and reality
    PHARMACOPSYCHIATRY
    
    J. Horacek, "Novel antipsychotics and extrapyramidal side effects. Theory and reality", PHARMACOPS, 33, 2000, pp. 34-42
95. Huey, KA; Powell, FL
    Time-dependent changes in dopamine D-2-receptor mRNA in the arterial chemoreflex pathway with chronic hypoxia
    MOLECULAR BRAIN RESEARCH
    
    K.A. Huey e F.L. Powell, "Time-dependent changes in dopamine D-2-receptor mRNA in the arterial chemoreflex pathway with chronic hypoxia", MOL BRAIN R, 75(2), 2000, pp. 264-270
96. Muruganandam, AV; Ghosal, S; Bhattacharya, SK
    The role of xanthones in the antidepressant activity of Hypericum perforatum involving dopaminergic and serotonergic systems
    BIOGENIC AMINES
    
    A.V. Muruganandam et al., "The role of xanthones in the antidepressant activity of Hypericum perforatum involving dopaminergic and serotonergic systems", BIOG AMINE, 15(5), 2000, pp. 553-567
97. Smith, Y; Kieval, JZ
    Anatomy of the dopamine system in the basal ganglia
    TRENDS IN NEUROSCIENCES
    
    Y. Smith e J.Z. Kieval, "Anatomy of the dopamine system in the basal ganglia", TRENDS NEUR, 23(10), 2000, pp. S28-S33
98. Varrone, A; Fujita, M; Verhoeff, NPLG; Zoghbi, SS; Baldwin, RM; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
    Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans
    JOURNAL OF NUCLEAR MEDICINE
    
    A. Varrone et al., "Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans", J NUCL MED, 41(8), 2000, pp. 1343-1351
99. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
    Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone
    JOURNAL OF NUCLEAR MEDICINE
    
    V. Kaasinen et al., "Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone", J NUCL MED, 41(1), 2000, pp. 65-70
100. Stip, E; Liddle, PF; Soucy, JP
     Need for a new framework to understand the mechanism of all antipsychotics
     JOURNAL OF CLINICAL PSYCHIATRY
     
     E. Stip et al., "Need for a new framework to understand the mechanism of all antipsychotics", J CLIN PSY, 61(5), 2000, pp. 387-388